The Back Pain Consortium Research Program Study
clinical trial
Press Enter · cited answer in seconds
0 sources
The Back Pain Consortium Research Program Study
Summary
The Back Pain Consortium Research Program Study is a clinical trial[1].
Key Facts
- The Back Pain Consortium Research Program Study is in the country of United States[2].
- The Back Pain Consortium Research Program Study's instance of is recorded as clinical trial[3].
- The Back Pain Consortium Research Program Study's start time is recorded as +2021-06-09T00:00:00Z[4].
- The Back Pain Consortium Research Program Study's end time is recorded as +2027-06-30T00:00:00Z[5].
- The Back Pain Consortium Research Program Study's main subject is recorded as pain[6].
- The Back Pain Consortium Research Program Study's number of participants is recorded as {'unit': '1', 'amount': '+500'}[7].
- The Back Pain Consortium Research Program Study's title is recorded as University of Michigan Mechanistic Research Center -The Back Pain Consortium Research Program[8].
- The Back Pain Consortium Research Program Study's short name is recorded as BACPAC[9].
- The Back Pain Consortium Research Program Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+25'}[10].
- The Back Pain Consortium Research Program Study's ClinicalTrials.gov ID is recorded as NCT04870957[11].
- The Back Pain Consortium Research Program Study's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+70'}[12].
- The Back Pain Consortium Research Program Study's research intervention is recorded as duloxetine hydrochloride[13].
- The Back Pain Consortium Research Program Study's research intervention is recorded as serotonin–norepinephrine reuptake inhibitor[14].
- The Back Pain Consortium Research Program Study's research intervention is recorded as membrane transport modulator[15].
- The Back Pain Consortium Research Program Study's research intervention is recorded as mechanism of action[16].
- The Back Pain Consortium Research Program Study's research intervention is recorded as neurotransmitter agent[17].
- The Back Pain Consortium Research Program Study's research intervention is recorded as analgesic[18].
- The Back Pain Consortium Research Program Study's research intervention is recorded as peripheral nervous system agent[19].
- The Back Pain Consortium Research Program Study's research intervention is recorded as antidepressant[20].
- The Back Pain Consortium Research Program Study's research intervention is recorded as psychotropic drug[21].
- The Back Pain Consortium Research Program Study's research intervention is recorded as dopaminergic[22].
- The Back Pain Consortium Research Program Study's clinical trial phase is recorded as phase IV clinical trial[23].
- The Back Pain Consortium Research Program Study's research site is recorded as University of Michigan[24].
- The Back Pain Consortium Research Program Study's research subject recruitment status is recorded as recruiting[25].
- The Back Pain Consortium Research Program Study's study type is recorded as interventional study[26].